ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2262

Increased Risk of Sarcoidosis Among Patients with Celiac Disease: A Systematic Review and Meta-Analysis

Patompong Ungprasert1, Karn Wijarnpreecha2, Panadeekarn Panjawatanan3, Ploypin Lertjitbanjong2 and Juan Corral4, 1Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Internal medicine, Bassett medical center, cooperstown, NY, 3Medicine, Chiang Mai University, Chiang Mai, Thailand, 4Internal medicine, Mayo Clinic, Jacksonville, Jacksonville, FL

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, meta-analysis, risk and sarcoidosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster III: Sarcoid, Inflammatory Eye Disease, and Autoinflammatory Disease

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Increased Risk of Sarcoidosis among Patients with Celiac Disease: A Systematic Review and Meta-Analysis

 

Abstract

Background/Purpose: Several epidemiologic studies have suggested that patients with celiac disease may be at an increased risk of sarcoidosis but the results were inconsistent. This systematic review and meta-analysis was conducted with the aim to better characterize this risk by summarizing all available data.

Methods: A literature review was performed using MEDLINE and EMBASE database from inception to April 2018 using the search strategy that included the terms for sarcoidosis and celiac disease. Cohort studies or case-control studies that compared the risk of sarcoidosis among patients with celiac disease versus individuals without celiac disease were included. For cohort studies, cases must be patients with celiac disease, comparators must be individuals without celiac disease and the outcome of interest must be incident sarcoidosis. For case-control studies, cases must be patients with sarcoidosis, controls must be individuals without sarcoidosis and the exposure of interest must be celiac disease. Point estimates and standard errors of the included studies were extracted and the pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using a random-effect, generic inverse variance method of DerSimonian and Laird.

Results: Of 375 retrieved articles, a total of 4 studies (2 cohort studies and 2 case-control studies) with 693,639 participants met the eligibility criteria and were included into the meta-analysis. The risk of sarcoidosis among patients with celiac disease was significantly higher than individuals without celiac disease with the pooled OR of 7.16 (95% CI, 1.48 – 34.56). The statistical heterogeneity of this study was high (I2 = 95%). The forest plot of this meta-analysis is shown as figure 1.

Conclusion: This systematic review and meta-analysis found a significantly higher risk of sarcoidosis among patients with celiac disease.

 

Figure 1: Forest plot


Disclosure: P. Ungprasert, None; K. Wijarnpreecha, None; P. Panjawatanan, None; P. Lertjitbanjong, None; J. Corral, None.

To cite this abstract in AMA style:

Ungprasert P, Wijarnpreecha K, Panjawatanan P, Lertjitbanjong P, Corral J. Increased Risk of Sarcoidosis Among Patients with Celiac Disease: A Systematic Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/increased-risk-of-sarcoidosis-among-patients-with-celiac-disease-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-risk-of-sarcoidosis-among-patients-with-celiac-disease-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology